Involved in the Impulsis study (NEJM 2014) of the 1st novel ILD / IPF drug NINTEDANIB (one of only 3 Indian sites chosen). This drug reduced the decline in FVC by approximately 50% in patients on NINTEDANIB compared to placebo.
His work was featured in a documentary in Al Jazeera